Hepatitis Testing/Diagnosis Market is growing at a CAGR of 5% from 2024 to 2030 by Exactitude Consultancy
The Exactitude Consultancy Hepatitis Testing/Diagnosis Market Report โ Size, Trends, and Forecast 2024-2030
LUTON, BEDFORDSHIRE, UNITED KINGDOM, March 8, 2024 /EINPresswire.com/ -- ****Everything You Need to Know About Hepatitis Testing/Diagnosis everything is Here....!
The Comprehensive study onย ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ includes historical data as well as share, size, and projection information for the major players, geographies, applications, and product categories for the years 2024 to 2030. The Market study includes comprehensive insights on the competitive environment, description, broad product portfolio of key players, SWOT analysis, and significant business strategy implemented by rivals, revenue, Porters Five Forces Analysis, and sales projections. The report also features an impact analysis of the market dynamics, highlighting the factors currently driving and limiting market growth, and the impact they could have on the short, medium, and long-term outlook. The main goal of the paper is to further illustrate how the latest scenario, the economic slowdown, and war events affect the market for Hepatitis Testing/Diagnosis.
๐๐ก๐ ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ง๐ญ๐ข๐๐ข๐ฉ๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐ญ๐จ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐๐ญ ๐ ๐๐๐๐ ๐จ๐ ๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐. ๐๐ก๐ ๐ข๐ง๐๐ซ๐๐๐ฌ๐ข๐ง๐ ๐ข๐ง๐ญ๐๐ซ๐๐ฌ๐ญ ๐จ๐ ๐ญ๐ก๐ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐๐ฅ๐ฌ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ข๐ฌ ๐ญ๐ก๐๐ญ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ซ๐๐๐ฌ๐จ๐ง ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ฑ๐ฉ๐๐ง๐ฌ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ.
๐๐ก๐ ๐๐จ๐ฉ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ฉ๐ซ๐จ๐๐ข๐ฅ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:
Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories Inc., Siemens, DiaSorin, QIAGEN, Danaher, bioMรฉrieux SA, Grifols S.A., Ortho Clinical Diagnostics, FUJIREBIO Inc and Others.
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ:
In 2021, Abbott received FDA Emergency Use Authorization (EUA) for the Alinity m Resp-4-Plex assay.
In 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics (US) which aimed at adding more products to Rocheโs molecular diagnostics portfolio and the global distribution of products offered by GenMark Diagnostics.
In 2021, Bio-Rad Laboratories, Inc. partnered with Seegene, Inc. (South Korea). The partnership aims at collaborative development and the commercialization of infectious disease diagnostic
๐๐ฅ๐ข๐๐ค ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค ๐ญ๐จ ๐ ๐๐ญ ๐ ๐๐ซ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ :
https://exactitudeconsultancy.com/reports/10753/hepatitis-testing-diagnosis-market/#request-a-sample
(*If you have any special requirements, please let us know and we will provide you with the report as you wish.)
๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ฒ๐ฉ๐, ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง)
Hepatitis B
Hepatitis C
Other Hepatitis
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ, ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง)
Elisa
RDT
PCR
INAAT
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ง๐-๐๐ฌ๐๐ซ, ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง)
Hospitals
Diagnostic Laboratories
Blood Banks
๐๐๐ฌ๐๐ ๐จ๐ง ๐ ๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ, ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐จ๐ซ ๐๐ข๐ฌ๐ซ๐ฎ๐ฉ๐ญ๐ข๐จ๐ง๐ฌ ๐ก๐๐ฌ ๐๐๐๐ง ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฌ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ฌ:
North America dominates the global market, and this trend is expected to continue during the forecast period. The rising prevalence of hepatitis, as well as increased research and clinical trials for hepatitis testing in the United States, are the reason for this regionโs growth.
๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐ ๐๐จ๐ข๐ง๐ญ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ข๐ง ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ซ๐๐๐ญ๐จ๐ซ๐ฒ:
To study and analyze the global market size (value & volume) by company, key regions/countries, products and application, history data, and forecast to 2030.
To understand the structure of market by identifying its various sub segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the growth trends, future prospects, and their contribution to the total market.
To project the value and volume of submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
๐๐๐ค๐ ๐ ๐ฅ๐จ๐จ๐ค ๐๐ญ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ ๐ก๐๐ซ๐:
https://exactitudeconsultancy.com/reports/10753/hepatitis-testing-diagnosis-market/
๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ
๐๐๐๐๐๐๐: ๐๐ข๐ ๐ก ๐๐ฎ๐ซ๐๐๐ง ๐จ๐ ๐ก๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ
Hepatitis is a major public health concern with a high prevalence rate worldwide, despite significant improvements in treatment options, vaccination coverage, and public awareness. Of all the hepatitis types, B and C are the most prevalent and contribute toward higher mortality rates. In 2019, an estimated 296 million and 58 million people were living with chronic HBV and chronic HCV infection, respectively. In underdeveloped countries, the prevalence of hepatitis is high as compared to developed countries
๐๐๐๐๐๐๐๐๐๐: ๐๐๐๐ค ๐จ๐ ๐ฆ๐๐ง๐๐๐ญ๐๐ฌ ๐๐จ๐ซ ๐ง๐ฎ๐๐ฅ๐๐ข๐ ๐๐๐ข๐ ๐ญ๐๐ฌ๐ญ๐ฌ ๐ข๐ง ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ข๐๐ฌ
In developing and low-resource countries, NAT is not mandatory due to the expensive nature of this test and the requirement of skilled personnel. In India, by 2016, only 58 out of a total of 2,550 (~2%) blood banks performed NAT for hepatitis diagnosis. In many developing countries such as India and China, ELISA is the only mandatory test, which acts as a major inhibitor for the adoption of NAT. In India, blood screening involves serological testing for hepatitis surface antigens; however, there are no mandates for using NAT. As a result, there is a lack of clarity about results among people undergoing hepatitis diagnostic tests, which acts as a restraint for market growth.
๐๐๐๐๐๐๐๐๐๐๐๐๐: ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐๐ข๐จ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ข๐จ๐ฉ๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ข๐๐ฌ
The demand for immunoassay instruments and consumables is high in the biotechnology and biopharmaceutical industries. As a result, the growth of these industries is expected to support the growth of the market during the forecast period. In these industries, the growth of the end-user base has compelled many companies to launch new products and invest in developing advanced products. This is considered a positive indicator for market growth asย immunoassaysย are applied at many stagesโ from product development and manufacturing to quality controlโin production.
๐๐๐๐๐๐๐๐๐๐: ๐๐ฉ๐๐ซ๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ซ๐ซ๐ข๐๐ซ๐ฌ
Clinical laboratories across major markets are still evolving; technicians face operational challenges in ensuring effective sample procurement, storage, and transportation, especially while adopting novel technologies such as NGS and lab-on-a-chip PCR devices. Laboratory space also needs to be reconfigured to meet the requirements of conducting specific molecular diagnostic tests used for pathogen detection as a means of avoiding cross-contamination and ensuring efficient time management. This results in considerable cost escalation to maintain and operate advanced molecular diagnostic instruments, particularly those capable of handling a single sample type. Furthermore, due to the rapid mutation of microbes and the increasing outbreak of epidemics, clinical laboratories need to adopt innovative technologies capable of rapid sample diagnosis. However, the shortage of skilled and technically knowledgeable laboratory technicians to operate advanced hepatitis testing products has hindered their overall adoption, particularly in emerging markets.
๐๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ฉ๐จ๐ข๐ง๐ญ๐๐ซ๐ฌ:
๐๐๐ซ๐ค๐๐ญ ๐๐๐ง๐๐ญ๐ซ๐๐ญ๐ข๐จ๐ง: Comprehensive information on the product portfolios of the top players in the Hepatitis Testing/Diagnosis
๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ/๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ฌ๐ฌ๐๐ฌ๐ฌ๐ฆ๐๐ง๐ญ: In-depth assessment of the Hepatitis Testing/Diagnosis market strategies, geographic and business segments of the leading players in the market.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ฏ๐๐ซ๐ฌ๐ข๐๐ข๐๐๐ญ๐ข๐จ๐ง: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Hepatitis Testing/Diagnosis
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ช๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐ฌ๐๐ซ๐ฎ๐ญ๐ข๐ง๐ข๐ณ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐๐ซ๐:
Which companies are expanding litanies of products with the aim to diversify product portfolio?
Which companies have drifted away from their core competencies and how have those impacted the strategic landscape of the Hepatitis Testing/Diagnosis market?
Which companies have expanded their horizons by engaging in long-term societal considerations?
Which firms have bucked the pandemic trend and what frameworks they adopted to stay resilient?
What are the marketing programs for some of the recent product launches?
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ข๐ง๐ค๐ฌ:
https://exactitudeconsultancy.com/ko/reports/10753/hepatitis-testing-diagnosis-market/
https://exactitudeconsultancy.com/zh-CN/reports/10753/hepatitis-testing-diagnosis-market/
https://exactitudeconsultancy.com/ja/reports/10753/hepatitis-testing-diagnosis-market/
https://exactitudeconsultancy.com/fr/reports/10753/hepatitis-testing-diagnosis-market/
https://exactitudeconsultancy.com/de/reports/10753/hepatitis-testing-diagnosis-market/
๐๐ ๐จ๐๐๐๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ ๐๐๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฌ ๐๐๐ฌ๐ญ๐ข๐ง๐ /๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐๐ฅ๐ข๐๐ง๐ญ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ๐ฌ:
20% free customization.
Five Countries can be added as per your choice.
Five Companies can add as per your choice.
Free customization for up to 40 hours.
After-sales support for 1 year from the date of delivery.
๐๐๐ญ ๐๐จ๐ซ๐:https://exactitudeconsultancy.com/primary-research/
Thank you for your interest in the Hepatitis Testing/Diagnosis Market research publications;ย you can also get individual chapters or regional/country report versions such as Germany, France, China, Latin America, GCC, North America, Europe or Asiaโฆโฆ
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
๐๐ฑ๐๐๐ญ๐ข๐ญ๐ฎ๐๐ ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐๐ง๐๐ฒ is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
๐๐จ๐ง๐ญ๐๐๐ญ:
Irfan T
Exactitude Consultancy
+1 704-266-3234
email us here
Visit us on social media:
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.